Pickup J., and Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25 (2002) 593-598
Radermecker R.P., and Scheen A.J. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab. Res. Rev. 20 (2004) 178-188
Guilhem I., Leguerrier A.M., Lecordier F., Poirier J.Y., and Maugendre D. Technical risks with subcutaneous insulin infusion. Diabetes Metab. 32 (2006) 279-284
Mecklenburg R.S., Benson E.A., Benson Jr. J.W., Fredlund P.N., Guinn T., Metz R.J., et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 252 (1984) 3265-3269
Chantelau E., Lange G., Sonnenberg G.E., and Berger M. Acute cutaneous complications and catheter needle colonization during insulin-pump treatment. Diabetes Care 10 (1987) 478-482
Radermecker R.P., Legrand D.A., and Scheen A.J. Continuous subcutaneous insulin therapy in type 1 diabetic patients: retrospective study of about 500 patient-years. Diabetologia 48 Suppl 1 (2005) A328 (abstract)
Tanner M.H., and Liljenquist J.E. Toxic shock syndrome from Staphylococcus aureus infection at insulin pump infusion sites. Report of two cases. JAMA 259 (1998) 394-395
Teutsch S.M., Herman W.H., Dwyer D.M., and Lane J.M. Mortality among diabetic patient using continuous subcutaneous insulin-infusion pumps. N. Engl. J. Med. 310 (1984) 361-368
Castillo M.J., Scheen A., and Lefèbvre P.J. Treatment with insulin infusion pumps and ketoacidotic episodes: from physiology to troubleshooting. Diabetes Metab. Rev. 11 (1995) 161-177
Wertheim H.F.L., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5 (2005) 751-762
Lipsky B.A., Pecoraro R.E., Chen M.S., and Koepsell T.D. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 10 (1987) 483-486
Van Faassen I., Razenberg P.P.A., Simoons-Smit A.M., and van der Veen E.A. Carriage of Staphylococcus aureus and inflamed infusion sites with insulin-pump therapy. Diabetes Care 12 (1989) 153-155
Finkelstein R., Sobel J.D., Nagler A., and Merzbach D. Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. J. Med. 15 (1984) 193-211
Fowler Jr. V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., et al. ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 (2005) 3012-3021
